Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

Dengue virus (DENV) is the predominant mosquito-borne viral pathogen that infects humans with an estimated 50 to 100 million infections per year worldwide. Over the past 50 years, the incidence of dengue disease has increased dramatically and the virus is now endemic in more than 100 countries. More...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Byrd, Chelsea M., Grosenbach, Douglas W., Berhanu, Aklile, Dai, Dongcheng, Jones, Kevin F., Cardwell, Kara B., Schneider, Christine, Yang, Guang, Tyavanagimatt, Shanthakumar, Harver, Chris, Wineinger, Kristin A., Page, Jessica, Stavale, Eric, Stone, Melialani A., Fuller, Kathleen P., Lovejoy, Candace, Leeds, Janet M., Hruby, Dennis E., Jordan, Robert
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2013
Konular:
Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3623359/
https://ncbi.nlm.nih.gov/pubmed/23403421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02251-12
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller